Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001558370-25-004513
Filing Date
2025-04-07
Accepted
2025-04-07 08:42:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 avte-20250407x425.htm 425 56207
2 EX-99.1 avte-20250407xex99d1.htm EX-99.1 20591
  Complete submission text file 0001558370-25-004513.txt   78462
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filed by) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Subject) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40544 | Film No.: 25816472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)